Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity.
Signe StensenLiva L KroghAlexander H Sparre-UlrichFlemming DelaBolette HartmannTina VilsbøllJens Juul HolstMette Marie RosenkildeMikkel Bring ChristensenLaerke Smidt GasbjergFilip K Krag KnopPublished in: Diabetes, obesity & metabolism (2022)
Keyphrases
- weight loss
- weight gain
- metabolic syndrome
- liver failure
- insulin resistance
- type diabetes
- heart rate
- physical activity
- respiratory failure
- heart rate variability
- blood pressure
- body mass index
- drug induced
- binding protein
- adipose tissue
- high fat diet induced
- skeletal muscle
- body weight
- acute respiratory distress syndrome
- glycemic control